Expression and purification of recombinant HIV-1 tat protein using HIV-1-tat specific monoclonal antibodies

Anticancer Research

Volumn 20, Issue 4, 2000, Pages 2377-2381

  Demirhan, I ^a   Hofmann, D ^a   Chandra, A ^a   Hasselmayer, O ^a   Chandra, P ^a  

^a GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

Author keywords

HIV 1 tat gene; HIV 1 tat expression; HIV I tat monoclonal antibodies; Protein purification; Recombinant HIV 1 tat protein

Indexed keywords

MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION;

ANTIBODIES, MONOCLONAL; CHROMATOGRAPHY, AFFINITY; ESCHERICHIA COLI; GENE PRODUCTS, TAT; HIV-1; HUMANS; RECOMBINANT PROTEINS;

EID: 0033859131     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, Gallo RC: Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 67: 277-287, 1993.
2. Li CY, Friedman DJ, Wang C, Metelev V, Pardee AB: Induction of apoptosis in uninfected lymphocytes by Tat protein. Science 268: 429-431, 1995.
3. Demirhan I, Chandra A, Hasselmayer O, Chandra P: Intercellular traffic of human immunodeficiency virus type 1 transactivator protein defined by monoclonal antibodies. FEBS Lett 445: 53-56, 1999a.
4. Demirhan I, Chandra A, Hasselmayer O, Biberfeld P, Chandra P: Detection of distinct patterns of anti-tat antibodies in HIV-infected individuals with or without Kaposi's sarcoma. J. Acquir. Immune. Defict Syndr 22: 364-368, 1999b.
5. Buonaguro L, Buonaguro FM, Giraldo G, Ensoli B: The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-Iike structure. J Virol 68: 2677-2682, 1994.
6. Scala G, Ruocco MR, Ambrosino C, Mallardo M, Giordano V, Baldassarre F, Dragonetti E, Quinto I, Venuta S: The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein. J Exp Med 179: 961-971, 1994.
7. Westendorp MO, Li-Weber M, Frank RW and Krammer PH: Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J Virol 65: 4177-4185, 1994.
8. Masood R, Lunardi-Iskandar Y, Moudgil T, Zhang Y, Law RE, Huang CL, Puri RK, Levine AM, Gill PS IL-10 inhibits HIV-1 replication and is induced by tat. Biochemt Biophys Res Commun 202: 74-383, 1994.
9. Zauli G, Davis BR, Re MC, Visani G, Furlini G and La Placa M: Tat protein stimulates production of transforming growth factorbeta 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood 80: 3036-3042, 1992.
10. Goldstein G: HIV-1 Tat protein as a potential AIDS vaccine. Nature Med 2: 960-964, 1996.
11. Cohen SS, Li C, Ding L, Cao Y, Pardee AB, Shevach EM, Cohen DI: Pronounced acute immunosuppression in vivo mediated by HIV Tat challenge. Proc Natl Acad Sci USA 96: 10842-10847, 1999.
12. Zagury JF, Sill A, Blattner W, Lachgar A, Le Buanec H, Richardson M, Rappaport J, Hendel H, Bizini B, Gringeri A, Carcagno M, Criscuolo M, Burny A, Gallo RC, Zagury D: Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine. J Hum Virol 1; 282-292, 1998.